Abstract 4462: Nebivolol inhibits cell growth, inhibits autophagic flux, and enhances growth inhibition in combination with bicalutamide in prostate cancer cells.Swarnil Mandal, Meghana V. Trivedi, Chia‐Ling Wu et al.|Cancer Research|2026Cited by 0
Abstract 4461: Nebivolol exhibits cell growth inhibition in drug-resistant HR+/HER2- breast cancer and anti-tumoral synergism with abemaciclib <i>in vitro</i> .Chia‐Ling Wu, Shivaani Suresh Kanna, Meghana V. Trivedi|Cancer Research|2026Cited by 0